MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 23, 2023

Primary Completion Date

March 23, 2025

Study Completion Date

April 23, 2025

Conditions
MyocarditisMyocarditis AcutePericarditisPericarditis Acute
Interventions
DIAGNOSTIC_TEST

Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire

Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire will be used to follow the clinical outcomes and patient reported outcomes to assess for study objectives

OTHER

Baseline Quality of Life questionnaire

Only baseline quality of life questionnaires will be utilized in the alternative etiology myocarditis cohort as they will not be followed up in the study

Trial Locations (1)

V5Z 1M9

RECRUITING

Vancouver General Hospital, Vancouver

All Listed Sponsors
lead

Cardiology Research UBC

OTHER

NCT06103123 - MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study | Biotech Hunter | Biotech Hunter